Drug Impurity Analysis
Drug Impurity Analysis is a toxicological screening methodology that identifies and quantifies unintended chemical constituents in pharmaceutical substances, distinguishing itself by its focus on assessing the safety, origin, and structural characteristics of impurities arising during synthesis, degradation, or formulation.
550
Publications
15.6K
Citations
2.1K
Authors
509
Institutions
Publications per year
2017–2026
119
550
In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
Ying Han, Jingpu Zhang, Chang -qin Hu et al. · Frontiers in Pharmacology · 2019 · 285 citations · Full text
Marcelo Ribani, Carol H. Collins, Carla Beatriz Grespan Bottoli · Journal of Chromatography A · 2006 · 151 citations
The toxicological properties of impurities in malathion
W. N. Aldridge, James W. Miles, Dwight L. Mount et al. · Archives of Toxicology · 1978 · 150 citations
Pharmacy, Chemistry, Toxicology +7
1–5 of 550
2.1K
13
h-index
9
h-index
9
h-index
7
h-index
7
h-index
1–5 of 2.1K
509
Dr. Reddy's Laboratories (India)
Hyderabad, India
15 h-index
91 publications
2.2K citations
Eli Lilly (United States)
Indianapolis, United States
15 h-index
49 publications
2.1K citations
Gedeon Richter (Hungary)
Budapest, Hungary
14 h-index
77 publications
2.6K citations
Pfizer (United States)
New York, United States
13 h-index
53 publications
2.8K citations
Jawaharlal Nehru Technological University, Hyderabad
Hyderabad, India
13 h-index
18 publications
366 citations

Cairo University
Giza, Egypt
11 h-index
28 publications
569 citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
11 h-index
24 publications
1.2K citations
United States Military Academy
West Point, United States
10 h-index
21 publications
880 citations
1–8 of 509
149 publications · 3.6K citations
31
h-index
44 publications · 1.6K citations
24
h-index
28 publications · 894 citations
20
h-index
17 publications · 364 citations
14
h-index
19 publications · 576 citations
13
h-index
1–5